Pages
Products
CAG-ChR2-YFP AAV (Serotype 5)

CAG-ChR2-YFP AAV (Serotype 5)

Cat.No. :  AAV00089Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 5 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00089Z
Description CAG-ChR2-YFP AAV (Serotype 5) is the serotype 5 AAV which express Channelrhodopsin-2 under CAG promoter with YFP tag. Channelrhodopsins are a subfamily of opsin proteins that function as light-gated ion channels and very useful for many bioengineering and neuroscience applications such as photostimulation of neurons for probing of neural circuits. Using a Yellow Fluorescent Protein (YFP) tagged ChR2, light-stimulated axons and synapses can be identified in intact brain tissue. This is useful to study the molecular events during the induction of synaptic plasticity. ChR2 has also been used to map long-range connections from one side of the brain to the other, and to map the spatial location of specific inputs on the dendritic tree of individual neurons.
Serotype AAV Serotype 5
Target Gene CAG-ChR2-YFP
Product Type Adeno-associated virus
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Adeno-associated virus (AAV) has several properties that make it an attractive viral vector candidate for gene therapy applications. First, AAVs are non-pathogenic viruses, as there are no diseases associated with them. AAV vectors have also demonstrated the ability to stably integrate into the target genome, a property that is essential for gene therapy use, given that high levels of expression can be maintained without long-term effects on target cell function. Furthermore, due to having only ITRs, AAV vectors are also unable to interfere with the regulation of the inserted gene. More specifically, in contrast to all currently available gene editing platforms, a unique property of AAV vectors is the utilization of a homologous recombination pathway that does not involve exogenous nucleases, thus providing a highly precise editing process that maintains genome integrity without increasing the mutational burden at the target site. Due to this unique gene editing property, AAV vectors are currently the leading platform for in vivo gene therapy delivery. Another attractive feature is the very broad range of cells, tissues, and hosts that AAV can effectively transduce in vivo and in vitro, including dividing and non-dividing cells in humans, as well as murine, canine, NHPs, feline, and various other models. In addition to genetic properties, the unique physical properties of AAVs represent additional reasons why they should be used for gene therapy, such as ease of manipulation, resistance to pH changes, thermal changes, and detergents.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Bright and Clear Fluorescence

The YFP fluorescence from the CAG-ChR2-YFP AAV5 is bright and easily detectable under a standard fluorescent microscope, which is crucial for our in vivo imaging studies.

United States

02/09/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction